Fingerprint
Dive into the research topics of 'Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study
- behalf of the Israeli Acute Leukemia Working Group
- Rabin Medical Center Israel
- Tel Aviv University
- Soroka Medical Center
- Hebrew University of Jerusalem
- Assuta Medical Center
- Sheba Medical Center at Tel Hashomer
- Rambam Health Care Campus Israel
- Technion-Israel Institute of Technology
- Emek Medical Center
- Meir Hospital Sapir Medical Center
- Bnai-Zion Medical Center
- Cornell University
- Bar-Ilan University
- AbbVie
- Tel Aviv Sourasky Medical Center
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations